BML-259

• Description:

  BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  260.36

• Molecular Formula:

  C14H16N2OS

• Notes:

  Research use only, not for human use.

• Receptor:

  Antifungal|Antiviral

• CAS Number:

  267654-00-2